Guardant Health, Inc. (NASDAQ:GH) announced adding a full suite of immunohistochemistry to its portfolio of tumor molecular profiling tests. This addition will help oncologists identify the subtypes ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

The launch of the first immunohistochemistry (IHC ... scored by pathologists based on the percentage of tumour cells stained and the intensity of the staining. The FDA’s approval is based on data from ...

It involves staining an organism with crystal violet or methylene blue dye and then observing the organism under a microscope. Gram-positive bacteria have a thick peptidoglycan cell wall.

Research Center, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, Hebei Province 050011, China ...